Fingolimod induces BAFF and expands circulating transitional B cells without activating memory B cells and plasma cells in multiple sclerosis
- 25 October 2017
- journal article
- research article
- Published by Elsevier BV in Clinical Immunology
- Vol. 187, 95-101
- https://doi.org/10.1016/j.clim.2017.10.009
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labor and Welfare of Japan
This publication has 43 references indexed in Scilit:
- B cells in multiple sclerosis: connecting the dotsCurrent Opinion in Immunology, 2011
- Reduction of the Peripheral Blood CD56bright NK Lymphocyte Subset in FTY720-Treated Multiple Sclerosis PatientsThe Journal of Immunology, 2011
- CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus PatientsImmunity, 2010
- Cracking the BAFF codeNature Reviews Immunology, 2009
- FTY720 therapy exerts differential effects on T cell subsets in multiple sclerosisNeurology, 2008
- Interferon-β increases BAFF levels in multiple sclerosis: implications for B cell autoimmunityBrain, 2008
- Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zoneNature Immunology, 2004
- Normal B Cell Homeostasis Requires B Cell Activation Factor Production by Radiation-resistant CellsThe Journal of Experimental Medicine, 2003
- An Essential Role for BAFF in the Normal Development of B Cells Through a BCMA-Independent PathwayScience, 2001
- TACI-Ig Neutralizes Molecules Critical for B Cell Development and Autoimmune Disease: Impaired B Cell Maturation in Mice Lacking BLySImmunity, 2001